Cathy Burgess Discusses FDA Quality Metrics Initiative with The Gray Sheet (Audio)

Alston & Bird health care partner Cathy Burgess spoke about how the Food & Drug Administration’s (FDA) quality metrics initiative for pharmaceutical companies may also impact expectations for device manufacturers down the line. Click here to listen.